Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective

(1) Background: Numerous vaccines are under preclinical and clinical development for prevention of severe course and lethal outcome of coronavirus disease 2019 (COVID-19). In light of high efficacy rates and satisfactory safety profiles, some agents have already reached approval and are now distribu...

Descripción completa

Detalles Bibliográficos
Autores principales: Niebel, Dennis, Novak, Natalija, Wilhelmi, Jasmin, Ziob, Jana, Wilsmann-Theis, Dagmar, Bieber, Thomas, Wenzel, Joerg, Braegelmann, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470727/
https://www.ncbi.nlm.nih.gov/pubmed/34579181
http://dx.doi.org/10.3390/vaccines9090944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470727/
https://www.ncbi.nlm.nih.gov/pubmed/34579181
http://dx.doi.org/10.3390/vaccines9090944

Ejemplares similares